Royal Bank of Canada »

Peregrine Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 2.5M 6.42
2023-09-30 $24M 2.1M 11.32
2023-06-30 $30M 2.1M 14.20
2022-12-31 $23M 1.7M 12.90
2022-09-30 $0 1.1M 0.00
2021-06-30 $7.2M 279k 25.71
2021-03-31 $108k 5.9k 18.18
2020-12-31 $42k 3.6k 11.67
2020-09-30 $9.7k 1.6k 6.10
2020-06-30 $13k 1.6k 7.85
2020-03-31 $10k 1.8k 5.51
2019-12-31 $39k 5.2k 7.55
2019-09-30 $5.9k 879 6.67
2019-03-31 $1.0k 314 3.33
2018-12-31 $4.1k 886 4.59
2018-09-30 $16k 2.3k 7.16
2018-06-30 $4.5k 1.3k 3.44
2018-03-31 $4.5k 1.3k 3.44